| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 06 Nov 2026 | QUARTERLY REPORT |
| 06 Nov 2026 |
8-K: Results of Operations and Financial Condition
Expect to complete enrollment of the BCG-Unresponsive registrational cohort of the ADVANCED-2 trial of TARA-002 in NMIBC by year-end 2026 |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 11 Aug 2026 | REGISTRATION STATEMENT |
| 11 Aug 2026 | QUARTERLY REPORT |
| 11 Aug 2026 |
8-K: Results of Operations and Financial Condition
Expect to complete enrollment of the BCG-Unresponsive registrational cohort of the ADVANCED-2 trial in 4Q 2026 |
| 07 Jul 2026 | SCHEDULE 13G/A |
| 01 Jul 2026 |
Form 4: Shefferman Jesse, Director
Received 215,687 shares by exercise or conversion ($412K) · Sold 215,687 shares ($882K) · Gave 30,000 shares as a gift |
| 29 Jun 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Protara Therapeutics, Inc. (the “Company”) announced that Leonardo Viana Nicacio, M.D., Chief Medical Officer of the Company, resigned from the Company to explore other opportunities, effective as of June 26, 2026. Dr. Nicacio's duties w... |
| 29 Jun 2026 | 144 |
| 16 Jun 2026 |
Form 4: Levy Richard S, Director
Granted 31,000 Stock Option (Right to Buy) |
| 16 Jun 2026 |
Form 4: Solomon Michael Edward, Director
Granted 31,000 Stock Option (Right to Buy) |
| 16 Jun 2026 |
Form 4: Smith Cynthia, Director
Granted 31,000 Stock Option (Right to Buy) |
| 16 Jun 2026 |
Form 4: Sargen Gregory, Director
Granted 31,000 Stock Option (Right to Buy) |
| 16 Jun 2026 |
Form 4: Huang Jane, Director
Granted 31,000 Stock Option (Right to Buy) |
| 16 Jun 2026 |
Form 4: Garceau Roger, Director
Granted 31,000 Stock Option (Right to Buy) |
| 16 Jun 2026 |
Form 4: Flannelly Barry P, Director
Granted 31,000 Stock Option (Right to Buy) |
| 16 Jun 2026 |
Form 4: Beshar Luke M, Director
Granted 31,000 Stock Option (Right to Buy) |
| 15 Jun 2026 |
8-K: Submission of Matters to a Vote of Security Holders
The Annual Meeting of Stockholders (the “Annual Meeting”) of Protara Therapeutics, Inc. (the “Company”) was held on June 12, 2026. As of April 15, 2026, the record date for the Annual Meeting, there were 55,060,500 shares of the Company’... |
Loading...